Get started
Author

Bertrand Alexandre

Observed name: Alexandre, Bertrand
Institution: Celyad (Belgium)
Observed institution: Celyad (Belgium)
OpenAlex ID: A5011095959
Cardiopoietic cell therapy for advanced ischemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial
2016 · Jozef Bartunek, Andre Terzic, et al. · European Heart Journal · 212
Benefit of Cardiopoietic Mesenchymal Stem Cell Therapy on Left Ventricular Remodelling: Results from the Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) Study
2017 · John R. Teerlink, Marco Metra, et al. · European Journal of Heart Failure · 121
PDF
Chimeric Antigen Receptor-T Cells for Targeting Solid Tumors: Current Challenges and Existing Strategies
2019 · Lorraine Springuel, Caroline Lonez, et al. · BioDrugs · 68
PDF
Strategies for insulin initiation: insights from the French LIGHT observational study
2011 · Bruno Vergès, Jean Marcel Brun, et al. · Diabetes/Metabolism Research and Reviews · 23
ビル内廃棄物水熱回収:水流の特性化と省エネルギーとコストの評価のための都市規模法【Powered by NICT】
2017 · Bertrand Alexandre, Riad Aggoune, et al. · Applied Energy
総合的都市熱エネルギー評価と最適化のための家庭用温水消費の特性化【Powered by NICT】
2017 · Bertrand Alexandre, Mastrucci Alessio, et al. · Applied Energy
Cardiopoietic cell therapy for advanced ischemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled chart-1 clinical trial
2016 · Bartunek, Jozef, Terzic, Andre, et al. · ARAN (University of Galway Research Repository) (Ollscoil na Gaillimhe – University of Galway)
Chapelle de Biarritz
1857 · Bertrand Alexandre, Editeur Gaudin Alexis et Frère
Les Eaux-Bonnes
1857 · Bertrand Alexandre, Editeur Gaudin Alexis et Frère
Port de l'Impératrice
1857 · Bertrand Alexandre, Editeur Gaudin Alexis et Frère
Works count: 11
Citation count: 424
H-index: 4
I10-index: 4
Year
Topic
Type